Fluvoxamine augmentation in clozapine-resistant schizophrenia: An open pilot study

Biological Psychiatry

Volumn 40, Issue 7, 1996, Pages 671-674

  Silver, Henry ^a   Kushnir, Mina ^a   Kaplan, Alla ^a  

^a Flugelman Psychiatric Hospital   (Israel)

Author keywords

augmentation; clozapine; schizophrenia; SSRI; treatment resistant

Indexed keywords

CLOZAPINE; FLUVOXAMINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG COMBINATION; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; SCHIZOPHRENIA;

EID: 0030273281     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-3223(96)00170-9     Document Type: Article

References (15)

1. Andreasen NC (1983): Scale for the Assessment of Negative Symptoms (SANS). Iowa City: The University of Iowa.
2. Daniel DG, Randolph C, Jaskiw G, Handel S, Williams T, Abi-Dargham A, Shoaf S, Egan M, Elkashef A, Liboff S, et al (1994): Coadministration of fluvoxamine increases serum concentrations of haloperidol. J Clin Psychopharmacol 14:5: 340-343.
3. Goff D, Midha K, Brotman A, Waites M, Baldessarini R (1991): Elevation of plasma concentrations of haloperidol after addition of fluoxetine Am J Psychiatry 148:790-792.
4. Goff DC, Midha KK, Sarid-Segal O, Hubbard JW, Amico E (1995): A placebo controlled trial of fluoxetine added to neuroleptic in patients with schizophrenia. Psychopharmacology 117:417-423.
5. Guy W (1976): Assessment Manual for Psychopharmacology. Kensington: George Washington University.
6. Hiemke C, Weigmann H, Hartter S, Dahmen N, Wetzel H, Muller H (1994): Elevated levels of clozapine in serum after addition of fluvoxamine. J Clin Psychopharmacol 14:4:279-281 (letter).
7. Jerling M, Lindstrom L, Bondesson U, Bertilsson L (1994): Fluvoxamine inhibition and carbamezapine induction of the metabolism of clozapine: Evidence from a therapeutic drug monitoring service. Ther Drug Monit 164:368-374.
8. Meltzer H (1992): The importance of serotonin-dopamine interactions in the action of clozapine. Brit J Psychiatry 160 (suppl 17):22-29.
9. Meltzer H, Burnett S, Bastani B, et al (1990): Effect of six months of clozapine treatment on the quality of life of chronic schizophrenic patients. Hosp Community Psychiatry 41:892-897.
10. Overall JE, Gorham DR (1962): The Brief Psychiatric Rating Scale. Psychol Reports 10:799-812.
11. Silver H, Nassar A (1992): Fluvoxamine improves negative symptoms in treated chronic schizophrenia: An add on double blind placebo controlled study. Biol Psychiatry 31:698-704.
12. Silver H, Kaplan A, Kushnir M (1995a): Fluvoxamine augmentation in chronic schizophrenia: An open exploratory study. Hum Psychopharmacol 10:59-63.
13. Silver H, Kaplan A, Jahjah N (1995b): Fluvoxamine augmentation in clozapine resistant schizophrenia. Am J Psychiatry 152:1098.
14. Silver H, David D, Kaplan M, Hadjez J, Tobi N, Darnel A, Calev A, Lerer B (1993): An examination of the factor structure of schizophrenic symptoms and comparison of different rating scales. Schizophr Res 10:67-75.
15. Van Putten T, Marder SR, Wirshing WC, Aravagiri M, Chabert N (1991): Neuroleptic plasma levels. Schizophr Bull 17:2: 197-216.